1,106 material Form 8-K filings that 909 companies we cover made with the SEC in June 2026, each read and summarized by AI: what happened, the key figures, whether it reads positive or negative for shareholders, and how big a deal it is (impact 1-5). All of them were written later, when past filings were added: a selection, not every 8-K of the month (see the note below).
Enveric Biosciences filed a prospectus supplement on June 9, 2026, to offer an additional $2,425,000 of common stock through its existing at-the-market sales agreement with H.C. Wainwright & Co. The company has previously sold $4,483,711.04 of shares under that agreement, which dates to April 9, 2025. The filing adds to potential dilution for existing shareholders, but it does not disclose a financial result or a change in business operations.
Additional offering amount: $2,425,000 of common stock under the ATM Agreement dated April 9, 2025
Sales to date under the ATM Agreement before this filing: $4,483,711.04
Sales agent: H.C. Wainwright & Co., LLC; legal opinion filed as Exhibit 5.1 from Greenberg Traurig, LLP
Novanta agreed on June 8, 2026 to sell 2,142,857 common shares at $140.00 each in a private placement to institutional and accredited investors, for an aggregate purchase price of approximately $300.0 million before placement agent fees and expenses. The closing is expected on June 11, 2026, subject to customary conditions, and the company agreed to register the resale of the shares, which would add to the share count for existing holders.
Purchase price: $140.00 per share, 2,142,857 shares, about $300.0 million aggregate
Expected closing on or about June 11, 2026, subject to customary closing conditions
Post-closing count: 42,473,345 common shares outstanding or issuable under Tangible Equity Units, based on 35,613,303 shares outstanding as of June 8, 2026
Registration statement due within 30 days after closing; placement agents include J.P. Morgan Securities LLC and PNC Capital Markets LLC
Arch Capital Group completed a public offering of $2.0 billion in senior unsecured notes, split into $600 million due 2036 at 5.250% and $1.4 billion due 2056 at 5.950%. The notes add to the company's debt load, with interest paid semi-annually and the notes ranking behind obligations of its subsidiaries.
$600 million of 5.250% senior notes due June 15, 2036, and $1.4 billion of 5.950% senior notes due June 15, 2056
Interest is payable semi-annually on June 15 and December 15, starting December 15, 2026
Notes are effectively subordinated to obligations of the company's subsidiaries, including insurance and reinsurance policy obligations, and are not guaranteed by them
Notes were issued under a universal shelf registration on Form S-3 and a Third Supplemental Indenture dated June 9, 2026, with The Bank of New York Mellon as trustee
Affiliated Managers Group entered a Fourth Amended and Restated Credit Agreement on June 9, 2026, providing a $1.25 billion senior unsecured revolving credit facility with Bank of America as administrative agent. It replaces the company's prior credit agreement dated November 15, 2024, and borrowings may fund general corporate purposes, including repurchases of common stock and cash dividends.
Facility size is $1.25 billion, maturing June 9, 2031
Company may increase commitments by up to $750 million, subject to conditions
Covenants include leverage and interest coverage financial tests, plus limits on priority debt, asset sales and fundamental changes
On June 5, 2026, the company's operating partnership bought the Waterford Loan from NexBank Capital for $27.2 million, funded with borrowings under its revolving credit facility. The loan is a 10.00% fixed-rate term loan tied to the acquisition of a 240-unit multifamily property in North Carolina, and it marks the company's first deployment in its DST bridge-lending program. Because a director and officer of the company has ties to NexBank Capital and to the external adviser, the deal is a related-party transaction.
Purchase price of $27.2 million equal to outstanding principal plus accrued interest, funded through the revolving credit facility with JPMorgan Chase Bank, N.A.
Fixed interest rate of 10.00% per year, compounded monthly, with a stated maturity of January 14, 2028 and a 364-day extension option.
Loan bought without recourse except for breaches of representations; NexBank Capital must repurchase it if a material breach is not cured within 30 days, and claims survive 360 days.
A director and officer is a director of NexBank Capital and is linked to the parent of the external adviser, NexPoint Real Estate Advisors, L.P.
Sherwin-Williams amended its credit agreement with Goldman Sachs Bank USA as administrative agent. The primary purpose is to extend the maturity of $200 million of borrowing and letter of credit commitments from June 20, 2026 to June 20, 2031.
Amendment No. 11 was entered into on June 9, 2026 with Goldman Sachs Bank USA as administrative agent and Goldman Sachs Mortgage Company as issuing bank.
$200 million of commitments now mature June 20, 2031, up from June 20, 2026.
The filing states that certain lenders and their affiliates have provided and may provide other financial services to the company, for which they receive customary fees.
Briefs are written by AI from the filing text and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the AI's reading of the filing for shareholders, not a price forecast. Not investment advice.
Briefs marked “Written later” were written in November 2026 for filings that were by then more than three weeks old, so months before mid-October 2026 hold a selection: every material 8-K of the past year for the 100 largest companies we cover and the last 15 important 8-Ks of every other one. Briefs the number check holds back are not shown or counted. Also: the last 45 days, briefs by company, A–Z and the live SEC filings wire.